Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.
about
Antibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: An evidence-based literature reviewBacterial Infections in Hematopoietic Stem Cell Transplant RecipientsTracking Change: A Look at the Ecological Footprint of Antibiotics and Antimicrobial ResistanceAntimicrobial resistance in Acinetobacter baumannii: From bench to bedsideSuccessful treatment of extensively drug-resistant Acinetobacter baumannii peritoneal dialysis peritonitis with intraperitoneal polymyxin B and ampicillin-sulbactamIdentification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesisHigh and increasing Oxa-51 DNA load predict mortality in Acinetobacter baumannii bacteremia: implication for pathogenesis and evaluation of therapyCalcium binding-mediated sustained release of minocycline from hydrophilic multilayer coatings targeting infection and inflammationDetoxification of Indole by an Indole-Induced Flavoprotein Oxygenase from Acinetobacter baumanniiActivity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection ModelIdentification and Characterization of Cefotaxime Resistant Bacteria in Beef CattleLongitudinal analysis of the temporal evolution of Acinetobacter baumannii strains in Ohio, USA, by using rapid automated typing methodsBad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of AmericaHospital epidemiology and infection control in acute-care settings.A data-driven mathematical model of multi-drug resistant Acinetobacter baumannii transmission in an intensive care unitGenome-guided Investigation of Antibiotic Substances produced by Allosalinactinospora lopnorensis CA15-2(T) from Lop Nor region, China.Comparative proteomics of inner membrane fraction from carbapenem-resistant Acinetobacter baumannii with a reference strainShould we treat patients with only one set of positive blood cultures for extensively drug-resistant Acinetobacter baumannii the same as multiple sets?Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unitSelectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR) Acinetobacter baumannii HUMC1.Detection of KPC in Acinetobacter spp. in Puerto Rico.Multidrug resistant acinetobacter.Naturally competent Acinetobacter baumannii clinical isolate as a convenient model for genetic studies.A New Combination of a Pleuromutilin Derivative and Doxycycline for Treatment of Multidrug-Resistant Acinetobacter baumannii.Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittiiEpidemiological characterizations of class 1 integrons from multidrug-resistant acinetobacter isolates in Daejeon, Korea.Efficacy of Mastoparan-AF alone and in combination with clinically used antibiotics on nosocomial multidrug-resistant Acinetobacter baumanniiAntibiotic resistance determinants in Acinetobacter spp and clinical outcomes in patients from a major military treatment facility.Class 1 integrons and antibiotic resistance of clinical Acinetobacter calcoaceticus-baumannii complex in Poznań, Poland.Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination.Seasonal and temperature-associated increases in gram-negative bacterial bloodstream infections among hospitalized patients.Mathematical model to quantify the effects of risk factors on carbapenem-resistant Acinetobacter baumannii.The structure of alanine racemase from Acinetobacter baumannii.Diversity within the O-linked protein glycosylation systems of acinetobacter species.Acinetobacter baumannii-associated skin and soft tissue infections: recognizing a broadening spectrum of disease.The impact of inadequate terminal disinfection on an outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit.Epidemiology and clonality of carbapenem-resistant Acinetobacter baumannii from an intensive care unit in Palermo, ItalyPredictors of hospital mortality among septic ICU patients with Acinetobacter spp. bacteremia: a cohort study.Evolution of a pathogen: a comparative genomics analysis identifies a genetic pathway to pathogenesis in AcinetobacterDrug treatment for multidrug-resistant Acinetobacter baumannii infections.
P2860
Q26796605-6860E1BC-0BE9-48E8-92FF-2B9099486C78Q26799576-72E0AA86-261C-4BFA-8B06-242D30137547Q27007076-DEEC0230-5BEB-411C-A50E-84E6AA1B9FEAQ27024893-EAE6AC33-7668-4C1A-A1EF-9C05B6A27F14Q28271359-EADD0365-6620-4C27-883C-36948836FAD3Q28274696-3EA96230-D3A3-4AF6-A52B-FAB69143FEECQ28476377-A660453A-61B6-44AB-BEC8-CE734CEBE48EQ28538368-33A5DA96-18A9-4258-9FF8-D8245A21281BQ28548297-7C02DF69-9EDE-4770-9528-7D3DD30219FBQ28550341-527CBEE3-4ACB-4E73-8022-2DE92135E332Q28554231-12003FDA-FBFB-4430-8F96-CF2E7910A85FQ28730624-EEF944DC-64CF-46B7-B0BE-913590F66116Q29616084-BA706323-A114-4FE3-B137-5B79A03A4C0FQ30429049-E85B09F2-1E8A-4769-9ED1-5389511EB4B3Q30915186-81BB6456-1A5D-4798-9213-0DC852B3A51EQ31044149-53D1F764-06E0-46B2-8EFA-3DA51CE1A25BQ31071263-B5AA8B2B-434D-44CE-A671-7BC83CA27CE9Q33443422-78CC7519-B0C9-4D3D-91BE-1B1B21577D76Q33645064-07232D93-178D-4DD5-B896-0AA8A2C38857Q33649288-6FD3760F-F3A3-43F6-8851-EFDCF419530CQ33676198-7C74192B-ED98-473D-B4F6-666ACFD774CFQ33711902-2D59C4E9-2ABA-4064-8B58-D944D34D3B6EQ33769631-B583637B-7468-40D4-99E4-9D0A3DFCC401Q33792789-35D8D0DB-C1B0-403C-89F5-FEF5F9F51ADDQ33798301-EB2A4E12-B8FA-41C6-9858-74AD54709ADFQ33807604-E85DAE55-4028-4883-82B1-A0DCB5531835Q33817950-19D0E15E-189B-4F1A-A68E-CC0EAF16C86EQ33859312-CA75ED32-2913-4370-8C14-5179647A04E3Q33962826-7805DEDB-00FB-4B07-8ADF-F6B8B62094E1Q33997664-ABDFDB45-2D02-45C6-A676-D679EED7A703Q34038197-FCF2DCAD-63A9-4AB1-8B58-F7E846F68E91Q34057420-63C163C6-4A1C-4F9A-8782-3D79D4756F0FQ34147983-48B82457-EBA5-4F08-ADAA-F495253D07FCQ34157681-EE2DFF34-58B9-42C7-992B-17F7155D72B9Q34207603-854CA7B7-3CD8-4C57-9F75-7BCE8E2EC53DQ34257288-BDA4E5C5-355C-4CF6-9094-D7F55FAD939DQ34346675-B9210F8B-AB26-4D07-8A6C-0C47B0200171Q34437954-24FA4B44-B0AB-4124-AD20-B07C17DE053EQ34568285-70400E3C-CBA0-42BA-AC79-CE650180654FQ34601684-3ABCD669-93CC-45F8-BD9A-7645F734E59E
P2860
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.
@en
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.
@nl
type
label
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.
@en
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.
@nl
prefLabel
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.
@en
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.
@nl
P921
P356
P1476
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.
@en
P2093
Lisa L Maragakis
P304
P356
10.1086/529198
P407
P50
P577
2008-04-01T00:00:00Z